← Leaderboards
Xiao-Feng Yang
Temple Univ Of The Commonwealth
$16,352,501
Attributed
$18,199,392
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,199,392 · 9
By mechanism
R01$17,610,792 · 8
K08$588,600 · 1
Top collaborators
- Eric T Choi5 shared
- Hong Wang4 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Khalid Benamar$3,625,175
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsApolipoprotein EInflammationMolecularSignal TransductionBlood VesselsEndothelial CellsAtherosclerosisRegulatory T-LymphocyteReportingCellsLeadSuccessRisk FactorsPathway InteractionsGenesCardiovascular DiseasesMorbidity - Disease RateMonocytePublicationsFunctional DisorderInflammatoryHyperlipidemiaVascular Inflammation
Grant awards (42)
LysoPI/GPR55 pathway promotes endothelial activation, vascular inflammation and atherosclerosis$646,174
R01 · FY2025 · HL · contact PI
LysoPI/GPR55 pathway promotes endothelial activation, vascular inflammation and atherosclerosis$639,378
R01 · FY2024 · HL · contact PI
LysoPI/GPR55 pathway promotes endothelial activation, vascular inflammation and atherosclerosis$654,548
R01 · FY2023 · HL · contact PI
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation$648,249
R01 · FY2022 · HL · contact PI
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation$648,249
R01 · FY2021 · HL · contact PI
The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity$660,657
R01 · FY2020 · HL · contact PI
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation$651,703
R01 · FY2020 · HL · contact PI
IL-35 suppression of endothelial cell activation and atherosclerosis$562,024
R01 · FY2020 · HL · contact PI
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$703,248
R01 · FY2019 · HL
The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity$668,841
R01 · FY2019 · HL · contact PI
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation$659,271
R01 · FY2019 · HL · contact PI
IL-35 suppression of endothelial cell activation and atherosclerosis$570,784
R01 · FY2019 · HL · contact PI
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$703,248
R01 · FY2018 · HL
The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity$625,511
R01 · FY2018 · HL · contact PI
IL-35 suppression of endothelial cell activation and atherosclerosis$579,450
R01 · FY2018 · HL · contact PI
The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity$52,489
R01 · FY2018 · HL · contact PI
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$703,248
R01 · FY2017 · HL
The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity$632,501
R01 · FY2017 · HL · contact PI
IL-35 suppression of endothelial cell activation and atherosclerosis$587,696
R01 · FY2017 · HL · contact PI
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$645,335
R01 · FY2016 · HL
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease$382,500
R01 · FY2016 · HL · contact PI
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$20,344
R01 · FY2016 · HL · contact PI
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease$394,689
R01 · FY2015 · HL · contact PI
Roles of Interleukin-17 in Endothelial Cells$376,762
R01 · FY2015 · HL · contact PI
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease$460,326
R01 · FY2014 · HL · contact PI
Roles of Interleukin-17 in Endothelial Cells$374,850
R01 · FY2014 · HL · contact PI
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease$15,757
R01 · FY2014 · HL · contact PI
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease$364,140
R01 · FY2013 · HL · contact PI
Roles of Interleukin-17 in Endothelial Cells$364,140
R01 · FY2013 · HL · contact PI
Suppression of vascular endothelial cell inflammation$353,430
R01 · FY2013 · HL · contact PI
Roles of Interleukin-17 in Endothelial Cells$382,500
R01 · FY2012 · HL · contact PI
Suppression of vascular endothelial cell inflammation$371,250
R01 · FY2012 · HL · contact PI
Roles of Interleukin-17 in Endothelial Cells$382,500
R01 · FY2011 · HL · contact PI
Suppression of vascular endothelial cell inflammation$375,000
R01 · FY2011 · HL · contact PI
Suppression of vascular endothelial cell inflammation$375,000
R01 · FY2010 · HL · contact PI
Suppression of vascular endothelial cell inflammation$375,000
R01 · FY2009 · HL · contact PI
Survival of CD4+CD25+ Regulatory T Cells$122,040
K08 · FY2007 · AI · contact PI
Survival of CD4+CD25+ Regulatory T Cells$122,040
K08 · FY2006 · AI · contact PI
Survival of CD4+CD25+ Regulatory T Cells$79,012
K08 · FY2005 · AI
Survival of CD4+CD25+ Regulatory T Cells$43,028
K08 · FY2005 · AI
Survival of CD4+CD25+ Regulatory T Cells$111,240
K08 · FY2004 · AI
Survival of CD4+CD25+ Regulatory T Cells$111,240
K08 · FY2003 · AI